Paradoxical effects of human adipose tissue-derived mesenchymal stem cells on progression of experimental arthritis in SKG mice
- PMID: 25460084
- DOI: 10.1016/j.cellimm.2014.10.005
Paradoxical effects of human adipose tissue-derived mesenchymal stem cells on progression of experimental arthritis in SKG mice
Abstract
We evaluated the therapeutic effect of human adipose tissue-derived mesenchymal stem cells (hAd-MSCs) in a SKG arthritis model, a relevant animal model for human rheumatoid arthritis. hAd-MSCs were administered intraperitoneally into the mice for five consecutive days from on day 12 or 34 after arthritis induction, when the average clinical score was 0.5 or 5, respectively. They remarkably suppressed arthritis when administered on day 12. Disease suppression was correlated with reduction of pro-inflammatory cytokines and with increased levels of TGF-β and IL-10 from splenocytes. However, when hAd-MSCs were administered on day 34, the clinical scores were not improved, the histopathological scores were aggravated, and cytokine profiles were differed. Thus, hAd-MSCs showed paradoxical effects, according to the disease phase when they were administered. These suggest that the same cells acted differently depending on the disease progress, and cautions should be paid for safe and effective use of MSCs.
Similar articles
-
Comparative immunomodulatory properties of adipose-derived mesenchymal stem cells conditioned media from BALB/c, C57BL/6, and DBA mouse strains.J Cell Biochem. 2013 Apr;114(4):955-65. doi: 10.1002/jcb.24437. J Cell Biochem. 2013. PMID: 23225199
-
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.Arthritis Rheum. 2009 Apr;60(4):1006-19. doi: 10.1002/art.24405. Arthritis Rheum. 2009. PMID: 19333946
-
Human Adipose-Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses.Stem Cells. 2015 Dec;33(12):3493-503. doi: 10.1002/stem.2113. Epub 2015 Aug 18. Stem Cells. 2015. PMID: 26205964
-
Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.Clin Immunol. 2011 Dec;141(3):328-37. doi: 10.1016/j.clim.2011.08.014. Epub 2011 Sep 2. Clin Immunol. 2011. PMID: 21944669
-
Effects of Transplantation of CTLA4Ig-Overexpressing Adipose Tissue-Derived Mesenchymal Stem Cells in Mice With Sustained Severe Rheumatoid Arthritis.Cell Transplant. 2016;25(2):243-59. doi: 10.3727/096368915X688470. Epub 2015 Jun 17. Cell Transplant. 2016. PMID: 26087385
Cited by
-
Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications.Cells. 2020 Aug 7;9(8):1852. doi: 10.3390/cells9081852. Cells. 2020. PMID: 32784608 Free PMC article. Review.
-
Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.Int J Nanomedicine. 2021 Dec 31;16:8485-8507. doi: 10.2147/IJN.S334298. eCollection 2021. Int J Nanomedicine. 2021. PMID: 35002240 Free PMC article. Review.
-
Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?Front Immunol. 2021 Feb 24;12:643170. doi: 10.3389/fimmu.2021.643170. eCollection 2021. Front Immunol. 2021. PMID: 33732263 Free PMC article. Review.
-
Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells.J Clin Exp Hepatol. 2019 Jan-Feb;9(1):34-42. doi: 10.1016/j.jceh.2018.02.002. Epub 2018 Feb 16. J Clin Exp Hepatol. 2019. PMID: 30765937 Free PMC article.
-
Reestablish immune tolerance in rheumatoid arthritis.Front Immunol. 2022 Sep 30;13:1012868. doi: 10.3389/fimmu.2022.1012868. eCollection 2022. Front Immunol. 2022. PMID: 36248797 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources